High prices for generics in Australia - more competition might help

Australian Health Review

Volumn 33, Issue 2, 2009, Pages 200-214

  Bulfone, Liliana ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66749129097     PISSN: 01565788     EISSN: 14498944     Source Type: Journal    
DOI: 10.1071/AH090200     Document Type: Article

References (14)

1. Productivity Commission. International pharmaceutical price differences [research report]. Canberra: AusInfo, 2001.
2. Productivity Commission. Evaluation of the pharmaceutical industry investment program [research report]. Canberra: AusInfo, 2003.
3. Australian Government Department of Health and Ageing. Expenditure and prescriptions twelve months to 30 June 2007. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/pbs-stats-pbexp-jun07 (accessed Jan 2009).
4. Walmart Stores Inc. Walmart $4 Prescription Program. Available at: http://www.walmart.com/catalog/catalog.gsp?cat=546834 (accessed Jan 2009).
5. Abbott T. Pricing arrangements for generic medicines [media release ABB009/05]. 7 Feb 2005. Available at: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2005-taabb009.htm?OpenDocument&yr=2005&mth=2 (accessed Jan 2009).
6. Australian Government Department of Health and Ageing. Update (March 2005) questions and answers on new pricing and listing arrangements for generic medicines on the Pharmaceutical Benefits Scheme. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/8464B883F90180E1CA25732B0048D610/$File/qamar05.pdf (accessed Jan 2009).
7. Australian Government Department of Health and Ageing. Strenthening your PBS - preparing for the future [fact sheet]. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/Strengthening-your-PBS.htm (accessed Jan 2009).
8. Faunce T, Löfgren H. Drug price reforms: the new F1-F2 bifurcation. Aust Prescriber 2007; 30: 138-40.
9. Searles A, Jeffries S, Doran E, Henry DA. Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme. Med J Aust 2007; 187: 236-9.
10. Australian Government Department of Health and Ageing. Schedule of Pharmaceutical Benefits, May 2008. Available at: http://www.pbs.gov.au/html/healthpro/publication/view?date=20080501&type=FlashPaper&name=general-schedule (accessed Jan 2009).
11. Poundstone W. Prisoner's dilemma. New York: Doubleday, 1992.
12. Australian Government Department of Health and Ageing. National Medicines Policy 2000. Canberra: Ausinfo, 1999. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/National+Medicines+Policy-2 (accessed Jan 2009).
13. Hollis A. The effect of brand-controlled pseudogenerics on the Canadian pharmaceutical market. Can Public Policy 2003; 29 (1): 21-31.
14. Besanko D, Dranove D, Shanley M. The economics of strategy. New York: John Wiley, 1996.